CSF biomarkers within a Belgian allochthonous population ; Developing topics
Abstract Background Neuropsychological testing is difficult in allochthonous older individuals due to language, sociocultural, and educational differences with autochthones. Using biomarkers could help making early diagnosis of neurodegeneration in this population, but so far very few studies have investigated biomarker differences between allochthones and autochthones. We aimed to characterize the Alzheimer’s disease (AD) cerebrospinal fluid (CSF) biomarkers (protein TAU, amyloid β42, tau/amyloid β42 ratio and pTau) in autochthonous and allochthonous patients. Besides ethnic origin, we matche... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | Artikel |
Erscheinungsdatum: | 2020 |
Reihe/Periodikum: | Alzheimer's & Dementia ; volume 16, issue S5 ; ISSN 1552-5260 1552-5279 |
Verlag/Hrsg.: |
Wiley
|
Schlagwörter: | Psychiatry and Mental health / Cellular and Molecular Neuroscience / Geriatrics and Gerontology / Neurology (clinical) / Developmental Neuroscience / Health Policy / Epidemiology |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26498244 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | http://dx.doi.org/10.1002/alz.047125 |